Page last updated: 2024-09-03

n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate and Myocardial Ischemia

n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate has been researched along with Myocardial Ischemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harada, K; Jinno, Y; Miwa, A; Nakazawa, H; Nishikori, K; Ogawa, N; Ohta, H1
Grover, GJ1

Reviews

1 review(s) available for n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate and Myocardial Ischemia

ArticleYear
The role of ATP-sensitive potassium channels in myocardial ischemia: pharmacology and implications for the future.
    EXS, 1996, Volume: 76

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Benzopyrans; Cardiotonic Agents; Disease Models, Animal; Guanidines; Humans; Ischemic Preconditioning, Myocardial; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channels; Pyridines

1996

Other Studies

1 other study(ies) available for n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate and Myocardial Ischemia

ArticleYear
Effects of K+ channel openers on ischemic dysfunction and metabolic disturbance in isolated perfused rat heart.
    European journal of pharmacology, 1993, Feb-16, Volume: 231, Issue:3

    Topics: Animals; Benzopyrans; Cromakalim; Heart; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion; Pyridines; Pyrroles; Rats; Rats, Wistar; Vasodilator Agents

1993